How Much Can We Rely on the Level of Prostate-Specific Antigen as an End Point for Evaluation of Clinical Trials? A Word of Caution!
Open Access
- 19 June 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 88 (12) , 779-781
- https://doi.org/10.1093/jnci/88.12.779
Abstract
Mario A. Eisenberger, William G. Nelson; How Much Can We Rely on the Level of Prostate-Specific Antigen as an End Point for Evaluation of Clinical Trials? A WoKeywords
This publication has 0 references indexed in Scilit: